We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+20.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$176M
AUM Growth
+$107M
Cap. Flow
+$103M
Cap. Flow %
58.75%
Top 10 Hldgs %
4.24%
Holding
1,234
New
413
Increased
180
Reduced
1
Closed
640

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$895K
2
PLAB icon
Photronics
PLAB
+$774K
3
EW icon
Edwards Lifesciences
EW
+$755K
4
MMS icon
Maximus
MMS
+$754K
5
TTEK icon
Tetra Tech
TTEK
+$745K

Top Sells

Rank Stock Value
1
DK icon
Delek US
DK
+$197K
2
CSGP icon
CoStar Group
CSGP
+$197K
3
VIST icon
Vista Energy
VIST
+$197K
4
SKX
Skechers
SKX
+$196K
5
ALRS icon
Alerus Financial
ALRS
+$195K

Sector Composition

Rank Sector Weight
1 Healthcare 19.45%
2 Technology 17.59%
3 Industrials 17.43%
4 Consumer Discretionary 12.31%
5 Financials 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEFT icon
151
Euronet Worldwide
EEFT
$2.97B
$378K 0.22%
+3,812
New +$386K
SVC
152
Service Properties Trust
SVC
$1.11B
$377K 0.21%
+16,543
New +$411K
ATI icon
153
ATI
ATI
$27.5B
$377K 0.21%
5,633
+4,278
+316% +$266K
VRSN icon
154
VeriSign
VRSN
$24.9B
$376K 0.21%
+1,980
New +$357K
PLD icon
155
Prologis
PLD
$137B
$375K 0.21%
+2,972
New +$369K
NKE icon
156
Nike
NKE
$62B
$374K 0.21%
+4,236
New +$332K
VST icon
157
Vistra
VST
$57B
$370K 0.21%
3,120
+2,077
+199% +$176K
JACK icon
158
Jack in the Box
JACK
$279M
$370K 0.21%
7,940
+5,398
+212% +$271K
VREX icon
159
Varex Imaging
VREX
$465M
$369K 0.21%
+30,947
New +$394K
ADMA icon
160
ADMA Biologics
ADMA
$1.91B
$366K 0.21%
18,331
+11,898
+185% +$185K
CVNA icon
161
Carvana
CVNA
$43.4B
$366K 0.21%
+10,520
New +$302K
MYRG icon
162
MYR Group
MYRG
$6.09B
$365K 0.21%
3,575
+2,774
+346% +$315K
APP icon
163
Applovin
APP
$131B
$365K 0.21%
+2,798
New +$255K
VRT icon
164
Vertiv
VRT
$115B
$365K 0.21%
+3,665
New +$304K
KOP icon
165
Koppers
KOP
$972M
$364K 0.21%
9,971
+7,178
+257% +$268K
SHLS icon
166
Shoals Technologies Group
SHLS
$1.62B
$364K 0.21%
+64,910
New +$388K
HBAN icon
167
Huntington Bancshares
HBAN
$35B
$364K 0.21%
+24,759
New +$352K
AZEK
168
DELISTED
The AZEK Co
AZEK
$364K 0.21%
7,773
+3,362
+76% +$144K
WWD icon
169
Woodward
WWD
$24.9B
$363K 0.21%
2,114
+1,636
+342% +$272K
ATEX icon
170
Anterix
ATEX
$1.89B
$361K 0.21%
+9,582
New +$369K
SO icon
171
Southern Company
SO
$109B
$360K 0.21%
+3,997
New +$341K
FOR icon
172
Forestar Group
FOR
$1.45B
$358K 0.2%
+11,046
New +$344K
ANIP icon
173
ANI Pharmaceuticals
ANIP
$1.78B
$357K 0.2%
5,990
+3,266
+120% +$199K
PRO
174
DELISTED
PROS Holdings
PRO
$356K 0.2%
+19,218
New +$406K
XEL icon
175
Xcel Energy
XEL
$50.9B
$352K 0.2%
5,394
+2,905
+117% +$172K

Similar funds

EntryPoint Capital's Q3 2024 Portfolio in Review

As of Q3 2024, EntryPoint Capital held 1,234 positions worth $176M, up 157% from $68.4M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

EntryPoint Capital deployed $103M of net new capital in Q3 2024, opening 413 new positions and adding to 180 existing holdings. Its largest new stake was Guardant Health: 31,633 shares worth $726K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iRadimed, an estimated $8.4K trimmed.

  • EntryPoint Capital's largest Q3 2024 buy was Guardant Health: 31,633 shares worth $726K.
  • EntryPoint Capital added most to Edwards Lifesciences in Q3 2024, an estimated $755K increase.
  • EntryPoint Capital's biggest Q3 2024 reduction was iRadimed, cutting an estimated $8.4K.
  • EntryPoint Capital fully exited Delek US in Q3 2024, selling an estimated $197K.
  • EntryPoint Capital's ten largest holdings make up 4.2% of its $176M portfolio in Q3 2024.
  • EntryPoint Capital opened 413 new positions and closed 640 in Q3 2024.
  • EntryPoint Capital's portfolio value rose 157% quarter-over-quarter to $176M.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.